Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Target Controlled Infusion of Etomidate or Propofol for Anesthesia of Thoracoscopic Mitral Valve Replacement Surgery,A Randomized Controlled Double-Blinded Study

NCT02644980 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT02644980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02644980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Target Controlled Infusion of Etomidate or Propofol for Anesthesia of Thoracoscopic Mitral Valve Replacement Surgery,A Randomized Controlled Double-Blinded Study
Lead sponsor
Xijing Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
December 31, 2015
Completion date
August 31, 2016
Enrollment
110 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

delirium, hemodynamic instability